132 related articles for article (PubMed ID: 16140957)
1. Targeted destruction of c-Myc by an engineered ubiquitin ligase suppresses cell transformation and tumor formation.
Hatakeyama S; Watanabe M; Fujii Y; Nakayama KI
Cancer Res; 2005 Sep; 65(17):7874-9. PubMed ID: 16140957
[TBL] [Abstract][Full Text] [Related]
2. Targeted degradation of KRAS by an engineered ubiquitin ligase suppresses pancreatic cancer cell growth in vitro and in vivo.
Ma Y; Gu Y; Zhang Q; Han Y; Yu S; Lu Z; Chen J
Mol Cancer Ther; 2013 Mar; 12(3):286-94. PubMed ID: 23288781
[TBL] [Abstract][Full Text] [Related]
3. The ubiquitin ligase CHIP regulates c-Myc stability and transcriptional activity.
Paul I; Ahmed SF; Bhowmik A; Deb S; Ghosh MK
Oncogene; 2013 Mar; 32(10):1284-95. PubMed ID: 22543587
[TBL] [Abstract][Full Text] [Related]
4. MM-1 facilitates degradation of c-Myc by recruiting proteasome and a novel ubiquitin E3 ligase.
Kimura Y; Nagao A; Fujioka Y; Satou A; Taira T; Iguchi-Ariga SM; Ariga H
Int J Oncol; 2007 Oct; 31(4):829-36. PubMed ID: 17786314
[TBL] [Abstract][Full Text] [Related]
5. The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation.
Welcker M; Orian A; Jin J; Grim JE; Harper JW; Eisenman RN; Clurman BE
Proc Natl Acad Sci U S A; 2004 Jun; 101(24):9085-90. PubMed ID: 15150404
[TBL] [Abstract][Full Text] [Related]
6. E6AP ubiquitin ligase regulates PML-induced senescence in Myc-driven lymphomagenesis.
Wolyniec K; Shortt J; de Stanchina E; Levav-Cohen Y; Alsheich-Bartok O; Louria-Hayon I; Corneille V; Kumar B; Woods SJ; Opat S; Johnstone RW; Scott CL; Segal D; Pandolfi PP; Fox S; Strasser A; Jiang YH; Lowe SW; Haupt S; Haupt Y
Blood; 2012 Jul; 120(4):822-32. PubMed ID: 22689861
[TBL] [Abstract][Full Text] [Related]
7. Proteolytic control of the oncoprotein transcription factor Myc.
Thomas LR; Tansey WP
Adv Cancer Res; 2011; 110():77-106. PubMed ID: 21704229
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus X protein enhances Myc stability by inhibiting SCF(Skp2) ubiquitin E3 ligase-mediated Myc ubiquitination and contributes to oncogenesis.
Lee S; Kim W; Ko C; Ryu WS
Oncogene; 2016 Apr; 35(14):1857-67. PubMed ID: 26165841
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7.
Yada M; Hatakeyama S; Kamura T; Nishiyama M; Tsunematsu R; Imaki H; Ishida N; Okumura F; Nakayama K; Nakayama KI
EMBO J; 2004 May; 23(10):2116-25. PubMed ID: 15103331
[TBL] [Abstract][Full Text] [Related]
10. c-myc box II mutations in Burkitt's lymphoma-derived alleles reduce cell-transformation activity and lower response to broad apoptotic stimuli.
Kuttler F; Amé P; Clark H; Haughey C; Mougin C; Cahn JY; Dang CV; Raffeld M; Fest T
Oncogene; 2001 Sep; 20(42):6084-94. PubMed ID: 11593416
[TBL] [Abstract][Full Text] [Related]
11. Balance of Yin and Yang: ubiquitylation-mediated regulation of p53 and c-Myc.
Dai MS; Jin Y; Gallegos JR; Lu H
Neoplasia; 2006 Aug; 8(8):630-44. PubMed ID: 16925946
[TBL] [Abstract][Full Text] [Related]
12. Skp2 regulates Myc protein stability and activity.
Kim SY; Herbst A; Tworkowski KA; Salghetti SE; Tansey WP
Mol Cell; 2003 May; 11(5):1177-88. PubMed ID: 12769843
[TBL] [Abstract][Full Text] [Related]
13. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
Choe C; Chen N; Sawadogo M
Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
[TBL] [Abstract][Full Text] [Related]
14. The ubiquitin ligase HectH9 regulates transcriptional activation by Myc and is essential for tumor cell proliferation.
Adhikary S; Marinoni F; Hock A; Hulleman E; Popov N; Beier R; Bernard S; Quarto M; Capra M; Goettig S; Kogel U; Scheffner M; Helin K; Eilers M
Cell; 2005 Nov; 123(3):409-21. PubMed ID: 16269333
[TBL] [Abstract][Full Text] [Related]
15. HUWE1 upregulation has tumor suppressive effect in human prostate cancer cell lines through c-Myc.
Qu H; Liu H; Jin Y; Cui Z; Han G
Biomed Pharmacother; 2018 Oct; 106():309-315. PubMed ID: 29966975
[TBL] [Abstract][Full Text] [Related]
16. The CARM1-p300-c-Myc-Max (CPCM) transcriptional complex regulates the expression of
Lu W; Yang C; He H; Liu H
Int J Biol Sci; 2020; 16(6):1071-1085. PubMed ID: 32140074
[TBL] [Abstract][Full Text] [Related]
17. The MULE/HUWE1 E3 ubiquitin ligase is a tumor suppressor.
Cancer Discov; 2013 Jul; 3(7):OF32. PubMed ID: 23847377
[TBL] [Abstract][Full Text] [Related]
18. c-IAP1 cooperates with Myc by acting as a ubiquitin ligase for Mad1.
Xu L; Zhu J; Hu X; Zhu H; Kim HT; LaBaer J; Goldberg A; Yuan J
Mol Cell; 2007 Dec; 28(5):914-22. PubMed ID: 18082613
[TBL] [Abstract][Full Text] [Related]
19. Sirt1 deacetylates c-Myc and promotes c-Myc/Max association.
Mao B; Zhao G; Lv X; Chen HZ; Xue Z; Yang B; Liu DP; Liang CC
Int J Biochem Cell Biol; 2011 Nov; 43(11):1573-81. PubMed ID: 21807113
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of ubiquitination and stabilization of human ubiquitin E3 ligase PIRH2 by measles virus phosphoprotein.
Chen M; Cortay JC; Logan IR; Sapountzi V; Robson CN; Gerlier D
J Virol; 2005 Sep; 79(18):11824-36. PubMed ID: 16140759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
